400 Million

• Anthropic acquired Coefficient Bio, a startup founded eight months ago with fewer than 10 employees, for roughly $400 million in shares, despite it having no product or revenue. • The platform uses AI for pharmaceutical tasks like drug research planning and identifying new drug opportunities, positioning Anthropic's models for scientific discovery in life sciences. • This bet signals a strategic push into AI-driven biotech, potentially accelerating drug development amid growing competition in applied AI verticals.

• Anthropic acquired startup Coefficient Bio for more than $400 million to bolster its AI capabilities amid recent challenges like a source code leak. • The deal follows Anthropic's npm packaging error exposing Claude Code's source code, including memory architecture and model roadmap. • This acquisition strengthens Anthropic's position despite setbacks, potentially aiding future developments in autonomous AI features.

Researchers from Cold Spring Harbor Laboratory (CSHL) and global collaborators identified over 2.3 million conserved non-coding sequences (CNSs) across 314 plant genomes from 284 species, using a new computational tool called Conservatory. These ancient 'DNA switches' originated before flowering plants diverged from non-flowering ancestors more than 400 million years ago, with some confirmed essential for developmental functions through genetic editing. The discovery provides a comprehensive atlas for plant biology, aiding crop breeders in addressing drought and food shortages by fine-tuning traits. CSHL's Zachary Lippman described it as 'a new window into the evolution of life across eons.'